The COVID-19 pandemic was pivotal for governments and the pharmaceutical industry, highlighting critical gaps in global health preparedness. The pandemic revealed severe gaps and weaknesses in the pharmaceutical supply chain strategy used in the pre-pandemic era. In the aftermath, two distinct methods for addressing these weaknesses have emerged: one that emphasizes domestic-only preparedness, focusing on […]

The US pharmaceutical supply chain is heavily reliant on foreign manufacturing. A significant portion of drugs sold in the US are produced abroad, primarily in China. The numbers speak for themselves: According to the FDA, 72% of active pharmaceutical ingredient (API) facilities that supply the US market are located overseas. This overreliance on foreign production […]

The journey of developing a successful pharmaceutical product is a testament to the power of collaboration, innovation, and shared purpose. It’s a process that not only transforms molecules into life-saving treatments but also brings together diverse minds and talents to solve some of the most pressing health challenges. Being part of such a team is […]

The narrative of drug development often focuses on the eureka moments in the lab, the tireless research, and the groundbreaking discoveries. But this story’s another, frequently under-appreciated chapter – the crucial interaction with regulatory agencies. These institutions, acting as the gatekeepers of safety and efficacy, ensure the medications we rely on are genuinely beneficial. However, […]